Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(17)
•••
Comment by alphaseeking001on Jun 07, 2019 9:49am
142 Views
Post# 29805487

RE:RE:RE:RE:RE:RE:RE:RE:Question for QM45

RE:RE:RE:RE:RE:RE:RE:RE:Question for QM45Thanks again QM45!  

They did say in the September prelim results that they had 1 of the first 4 patients progress and leave the trial so I don't think we'll get 100% response.  Hopefully very good results will be announced however!  Fingers massively crossed as I agree, it's critical we show good results for two major reasons:  a) synergy with Keytruda... probably the biggest driver of value for us.  b) effectiveness in a completely different cancer type.

Like you and Qwerty... I just can't imagine they would put out a 2nd news release regarding the June 12 results if they weren't pretty solid... they are essentially highlighting the event on everyone's calendars... 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities